Venous thromboembolism (VTE), which includes both deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a major cause of morbidity and mortality in hospitalized …

Venous thromboembolism (VTE, ie, deep vein thrombosis [DVT] or pulmonary embolism
[PE]) is a common complication affecting approximately 25% of all hospitalized patients. The …

Venous thromboembolism (VTE), which includes deep venous thrombosis (DVT) and
pulmonary embolism (PE), remains an all too familiar risk for surgical patients, occurring in …

Perioperative venous thromboembolic (VTE) disease continues to be a clinical challenge
and remains a major health problem, with an annual incidence of approximately 500,000, of …

Incident venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and
pulmonary embolism (PE), accounts for $7 billion to $10 billion of United States health care …

One of the most difficult problems to address in the medical preoperative consultation is the
necessity of prophylaxis for deep vein thrombosis (DVT) and pulmonary embolism (PE). This …

Venous thromboembolic disease is the third most common cardiovascular disease after
atherosclerotic heart disease and stroke. It has been estimated that between 500,000 and …

Venous thromboembolism (VTE) is a serious pathophysiologic condition that is a major
cause of morbidity and mortality, especially during the perioperative period. A collective …

Deep vein thrombosis and pulmonary embolism is a well-recognised major health problem
in the West. There is a deep-rooted belief among clinicians that deep vein thrombosis is rare …

Venous thromboembolism (VTE) is a spectrum of diseases involving deep venous
thrombosis (DVT) and/or pulmonary embolism (PE). Without prophylaxis, the probable …